153 related articles for article (PubMed ID: 19879060)
1. Patterns of radiotherapy practice for pancreatic cancer in Japan: results of the Japanese Radiation Oncology Study Group (JROSG) survey.
Ogawa K; Ito Y; Karasawa K; Ogawa Y; Onishi H; Kazumoto T; Shibuya K; Shibuya H; Okuno Y; Nishino S; Ogo E; Uchida N; Karasawa K; Nemoto K; Nishimura Y;
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):743-50. PubMed ID: 19879060
[TBL] [Abstract][Full Text] [Related]
2. Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey.
Isohashi F; Ogawa K; Oikawa H; Onishi H; Uchida N; Maebayashi T; Kanesaka N; Tamamoto T; Asakura H; Kosugi T; Uno T; Ito Y; Karasawa K; Takayama M; Manabe Y; Yamazaki H; Takemoto M; Yoshioka Y; Nemoto K; Nishimura Y;
Radiat Oncol; 2013 Apr; 8():76. PubMed ID: 23547715
[TBL] [Abstract][Full Text] [Related]
3. Radical external beam radiotherapy for prostate cancer in Japan: preliminary results of the changing trends in the Patterns of Care process survey between 1996-1998 and 1999-2001.
Ogawa K; Nakamura K; Sasaki T; Yamamoto T; Koizumi M; Inoue T; Teshima T;
Jpn J Clin Oncol; 2004 Mar; 34(3):131-6. PubMed ID: 15078908
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience.
Rakhra S; Strauss JB; Robertson J; McGinn CJ; Kim T; Huang J; Blake A; Helenowski I; Hayes JP; Mulcahy M; Small W
J Gastrointest Cancer; 2016 Jun; 47(2):196-201. PubMed ID: 27112332
[TBL] [Abstract][Full Text] [Related]
5. Radical external beam radiotherapy for prostate cancer in Japan: preliminary results of the 1999-2001 patterns of care process survey.
Ogawa K; Nakamura K; Sasaki T; Yamamoto T; Koizumi M; Teshima T; Inoue T;
Jpn J Clin Oncol; 2004 Jan; 34(1):29-36. PubMed ID: 15020660
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.
Ben-Josef E; Shields AF; Vaishampayan U; Vaitkevicius V; El-Rayes BF; McDermott P; Burmeister J; Bossenberger T; Philip PA
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):454-9. PubMed ID: 15145162
[TBL] [Abstract][Full Text] [Related]
8. External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications.
Nishimura Y; Hosotani R; Shibamoto Y; Kokubo M; Kanamori S; Sasai K; Hiraoka M; Ohshio G; Imamura M; Takahashi M; Abe M
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):39-49. PubMed ID: 9300738
[TBL] [Abstract][Full Text] [Related]
9. Survival after chemoradiation in resected pancreatic cancer: the impact of adjuvant gemcitabine.
Baschnagel A; Shah C; Margolis J; Nadeau L; Stein J; Jury R; Robertson JM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e331-5. PubMed ID: 22420967
[TBL] [Abstract][Full Text] [Related]
10. [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
Wilkowski R; Thoma M; Heinemann V; Rau HG; Wagner A; Stoffregen C; Dühmke E
Strahlenther Onkol; 2003 Feb; 179(2):78-86. PubMed ID: 12590317
[TBL] [Abstract][Full Text] [Related]
11. Patterns of practice in the radiation therapy management of rectal cancer: survey of the Interregional Group Piedmont, Valle d'Aosta and Liguria of the "Associazione Italiana di Radioterapia Oncologica (AIRO)".
Di Genesio Pagliuca M; Turri L; Munoz F; Melano A; Bacigalupo A; Franzone P; Sciacero P; Tseroni V; Vitali ML; Delmastro E; Scolaro T; Marziano C; Orsatti M; Tessa M; Rossi A; Ballare A; Moro G; Grasso R; Krengli M
Tumori; 2013; 99(1):61-7. PubMed ID: 23549002
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
Allen AM; Zalupski MM; Robertson JM; Eckhauser FE; Simone D; Brown D; Hejna G; Normolle D; Lawrence TS; McGinn CJ
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1461-7. PubMed ID: 15275733
[TBL] [Abstract][Full Text] [Related]
13. External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study.
Mattiucci GC; Morganti AG; Valentini V; Ippolito E; Alfieri S; Antinori A; Crucitti A; D'Agostino GR; Di Lullo L; Luzi S; Mantini G; Smaniotto D; Doglietto GB; Cellini N
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):831-8. PubMed ID: 19427747
[TBL] [Abstract][Full Text] [Related]
14. Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation.
Golden DW; Novak CJ; Minsky BD; Liauw SL
Radiat Oncol; 2012 Sep; 7():156. PubMed ID: 22974515
[TBL] [Abstract][Full Text] [Related]
15. Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.
Brade A; Brierley J; Oza A; Gallinger S; Cummings B; Maclean M; Pond GR; Hedley D; Wong S; Townsley C; Brezden-Masley C; Moore M
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1027-36. PubMed ID: 17197132
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer.
Goldstein D; Van Hazel G; Walpole E; Underhill C; Kotasek D; Michael M; Shapiro J; Davies T; Reece W; Harvey J; Spry N
Br J Cancer; 2007 Aug; 97(4):464-71. PubMed ID: 17653074
[TBL] [Abstract][Full Text] [Related]
17. Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival.
Ogawa K; Ito Y; Hirokawa N; Shibuya K; Kokubo M; Ogo E; Shibuya H; Saito T; Onishi H; Karasawa K; Nemoto K; Nishimura Y;
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):559-65. PubMed ID: 22019243
[TBL] [Abstract][Full Text] [Related]
18. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
Crane CH; Abbruzzese JL; Evans DB; Wolff RA; Ballo MT; Delclos M; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Vauthey JN; Wong AB; Phan T; Nguyen Q; Janjan NA
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1293-302. PubMed ID: 11955742
[TBL] [Abstract][Full Text] [Related]
19. Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancer.
Short M; Goldstein D; Halkett G; Reece W; Borg M; Zissiadis Y; Kneebone A; Spry N
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):157-62. PubMed ID: 22543205
[TBL] [Abstract][Full Text] [Related]
20. [Effect of combined treatment methods on quality of life in patients with pancreatic cancer].
Brasiūniene B; Brasiūnas V; Juozaityte E
Medicina (Kaunas); 2006; 42(10):817-22. PubMed ID: 17090981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
